These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9530568)

  • 1. [Supraventricular tachyarrhythmias. Cardiac, extra-cardiac and arrhythmogenic side effects of anti-arrhythmia drugs].
    Meinertz T; Willems S; Weiss C
    Internist (Berl); 1998 Jan; 39(1):33-7. PubMed ID: 9530568
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination therapy with anti-arrhythmia agents].
    Kettner W; Götze C
    Z Arztl Fortbild (Jena); 1986; 80(21):889-92. PubMed ID: 2436386
    [No Abstract]   [Full Text] [Related]  

  • 3. [Magnesium as an anti-arrhythmic therapy principle in supraventricular and ventricular cardiac arrhythmias].
    Zehender M
    Z Kardiol; 1996; 85 Suppl 6():135-45. PubMed ID: 9064958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy and prevention of recurrence of supraventricular tachyarrhythmias].
    Steinbigler P; Haberl R; Steinbeck G
    Internist (Berl); 1998 Jan; 39(1):19-32. PubMed ID: 9530567
    [No Abstract]   [Full Text] [Related]  

  • 5. After a long time, the new ESC Guidelines for the management of patients with supraventricular tachycardia are here.
    Tamargo J
    Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):3-5. PubMed ID: 31800023
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cardiology update--I].
    Trappe HJ; Pfitzner P
    Med Klin (Munich); 1996 Apr; 91 Suppl 1():118-27. PubMed ID: 8657078
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute therapy of tachycardic arrhythmias. 1: Anti-arrhythmia agents, supraventricular tachycardia].
    Gonska BD; Rab J
    Fortschr Med; 1995 Feb; 113(6):73-6. PubMed ID: 7721225
    [No Abstract]   [Full Text] [Related]  

  • 8. [Risks and side effects in treatment of supraventricular tachycardia].
    Lüderitz B
    Z Gesamte Inn Med; 1993 Sep; 48(9):459-65. PubMed ID: 8212752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arrhythmogenic effects of anti-arrhythmia agents].
    Fillette F; Dupuis B; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1532-4. PubMed ID: 3099688
    [No Abstract]   [Full Text] [Related]  

  • 10. Neonatal ECG changes caused by supratherapeutic flecainide following treatment for fetal supraventricular tachycardia.
    Rasheed A; Simpson J; Rosenthal E
    Heart; 2003 Apr; 89(4):470. PubMed ID: 12639886
    [No Abstract]   [Full Text] [Related]  

  • 11. [Variants of arrhythmogenic action of anti-arrhythmia agents identified during choice of therapy by a transesophageal electrophysiological study].
    Rychkov AIu; Shurin MS; Shakhov GG
    Kardiologiia; 1993; 33(1):87-9. PubMed ID: 8035557
    [No Abstract]   [Full Text] [Related]  

  • 12. [Perioperative management of cardiac arrhythmia: part II].
    Zaballos García M; López Berlanga JL; Navia Roque J
    Rev Esp Anestesiol Reanim; 2006 Mar; 53(3):163-83; quiz 183, 193. PubMed ID: 16671260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arrhythmogenic effect of anti-arrhythmia drugs].
    Banasiak W; Metner E
    Wiad Lek; 1987 Jan; 40(2):100-5. PubMed ID: 3296463
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adenosine in the treatment of supraventricular arrhythmias].
    Lommi J; Pohjola-Sintonen S
    Duodecim; 1994; 110(5):473-7. PubMed ID: 7555840
    [No Abstract]   [Full Text] [Related]  

  • 15. Avoiding drug problems. The safety of drugs for supraventricular tachycardia.
    Reimold SC
    Eur Heart J; 1997 May; 18 Suppl C():C40-4. PubMed ID: 9152674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Magnesium: current studies--critical evaluation--consequences].
    Meinertz T
    Z Kardiol; 1996; 85 Suppl 6():147-51. PubMed ID: 9064959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic drugs for supraventricular tachycardia.
    Wellens HJ; Brugada P; Smeets JL
    Am J Cardiol; 1988 Dec; 62(19):69L-73L. PubMed ID: 3059790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy of supraventricular and ventricular tachyarrhythmias].
    Hohnloser SH
    Internist (Berl); 1996 Jan; 37(1):45-52. PubMed ID: 8837827
    [No Abstract]   [Full Text] [Related]  

  • 20. [Arrhythmogenic effect of anti-arrhythmia drugs].
    Trusz-Gluza M
    Kardiol Pol; 1991; 34(1):41-8. PubMed ID: 2051713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.